Katherine A. High
| Katherine A. High | |
|---|---|
| Born | Des Moines, Iowa |
| Nationality | American |
| Alma mater | Harvard College, University of North Carolina School of Medicine |
| Known for | Gene Therapy |
| Scientific career | |
| Fields | Hematology |
| Institutions | University of Pennsylvania, Spark Therapeutics |
| Academic advisors | Edward J. Benz, Jr. |
Katherine A. High is an American doctor who is a Emeritus Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. She is a co-founder, president and chief scientific officer of Spark Therapeutics.[1] High earned a A.B. in chemistry at the Harvard College in 1972 and a M.D in 1978 at University of North Carolina School of Medicine. She did her training in hematology with Edward J. Benz, Jr. at Yale University.[2]
Her work is focused on the use of gene therapy for hemophilia. She was the director of the Center for Cellular and Molecular Therapeutics, and as of 2001 head of hematology research,[1] at the Children's Hospital of Philadelphia and an investigator of the Howard Hughes Medical Institute.[3][4] High is a member of the Institute of Medicine and a fellow of the American Academy of Arts and Sciences.
References
- 1 2 Yarbrough, Cathy (3 September 2018). "Gene Therapy Pioneer's 30 Years Of Problem-Solving". Life Science Leader.
- ↑ Wilson, James M. (1 December 2016). "Interview with Katherine A. High, MD". Human Gene Therapy Clinical Development. 27 (4): 127–131. doi:10.1089/humc.2016.29021.int. ISSN 2324-8637. Retrieved 1 October 2017.
- ↑ "Katherine High" (PDF). Retrieved 1 October 2017.
- ↑ "Katherine A. High, MD - IHG Symposium 2015". IHG Symposium 2015. 1 September 2015. Retrieved 1 October 2017.